HomeAfricaAmericasAsia-PacificCaribbeanEuropeMiddle EastSouth AsiaWorldScienceMedicalFinancialEntertainmentZombie HuntersHardballLife LineThe Human RaceDead CenterZWN Special ReportsLettersMerchandiseLinksContact Us DisclaimerCopyrightsFAQ'sAbout ZWN


This site is for entertainment purposes only. All stories and events are fictional. Any similarities with persons either living or deceased in purely coincidental. There is occasional satirizing of prominent public figures. Contents of this site are copyrighted. All rights reserved.


Bookmark and Share



If you suspect anyone of showing sympoms of the 'Necro- Mortosis' Virus, the Government has released the following anonymous tip line.
1 800 155 3219


Amcalon Tests Vaccine
XL-6 Inhibitor.
California, USA
Posted: 5th, July. 2009
ZWN (AP)

Southern California based Amcalon released a short press statement on it's website today. The pharmaceutical giant announced that it had reached 'Phase four' in it's struggle to get the much anticipated 'XL-6 Inhibitor' drug into test markets.


Amcalon's road to launching this potential vaccine has been hampered by Government red tape, protracted FDA approval, and two administrations wildly differing views on stem cell research. ZWN's Science Editor Dr. Nancy Chan says "This is a hugely significant step forward. 'Phase four' is, according to FDA guidelines, a phase of post-approval surveillance. Post-marketing surveillance maintaines the safety of a drug in closely monitored test patient groups."

The whereabouts of all six test markets are a closely guarded secret at this time.

The only other significant contender in the potentially huge market of Necro-Mortosis vaccination is ImClonex Systems (nasdaq: IMCLX). However, they two are significantly hampered by the protracted legal process involved in bringing their own inhibitor - Ibrex to market.

Nasdaq rallied on good news from Amcalon's Phase IV trial for Mortosis vaccination. Shares of Amcalon were up 11.7%, or $9.65 to $103.56. However, ImClonex Systems (nasdaq: IMCLX) drug Ibrex, took a loss and was down off $4.52, or 3.9%, to $38.6



There are strict guidelines in the disposing of a corpse. Do not bury, burn or otherwise dispose of any deceased person. You are required by law to call your local authorities for collection and quarantine. The government has released a help number
1 800 155 1216
Medical & Health


How the virus works
- Unlocking the code 

 

Studying The Undead
ZWN Exclusive interview with Yale Psychologist Dr. Maria Perez
By ZWN Field reporter -
Ruth Ellis Haworth

Read Report:

Medical breakthrough - Hope found In new drug

Recent 'Body Trauma' report could change tactics